Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2018; 43(2): 280-284


Comparing the efficacy of nifedipine and nitroglycerine as tocolytic agent in preterm labor patients

Rahat Akhtar, Mustafa Awais, Momina Awais, Aamir Furqan.




Abstract

Objective: To compare the efficacy of nifedipine with nitroglycerine when used in preterm labor or pregnancy prolongation.
Methodology: This randomized control trial was conducted in the department of Gynecology and Obstetrics, Services Institute of Medical Sciences, Lahore, Pakistan from August 2016 to January 2017and None probably consecutive sampling technique was used. Patients were divided into two groups; group N (nifedepine) and group NG (nitroglycerine). Blinding was done by lottery method. The main outcome variable of our study was efficacy of drug.Data were analyzed through SPSS version 23.
Results: A total 72 females were included in the study. The mean age and gestational age of the patients was 25.36±3.8years and 32.09±1.78 weeks. Efficacy of drug used in group N was 88.9% and in group NG, efficacy was 61.1%. In group N, prolongation of pregnancy for 48 hours seen in 88.9% patients while in group NG this frequency was 61.1%.
Conclusion: Nifedipine was a better tocolytic agent than nitroglycerin for the preterm patients when used for pregnancy prolongation.

Key words: Nifedipine, nitroglycerine, preterm labor, tocolytic agent.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.